2010 |
|
|
September |
Announcement - Full recruitment into RA clinical trial |
|
August |
Appendix 3B |
|
August |
Announcement - patent portfolio development and clinical trial update |
|
August |
Appendix 3B |
|
August |
Appendix 4C clarification |
|
August |
Appendix 3B |
|
August |
Notice under S708a 5(e) |
|
July |
Appendix 4C |
|
July |
Appendix 3B |
|
July |
Notice under S708A(5)(e) of the Corporations Act |
|
July |
Appendix 3B |
|
June |
Clinical trial recruitment milestone |
|
June |
Statement |
|
June |
Appendix 3B |
|
June |
SPP Update |
|
June |
Appendix 3B |
|
June |
Results of General Meeting |
|
June |
Chairman's Address to General Meeting |
|
June |
Appendix 3B |
|
June |
Notice under Section 708A of the Corporations Act |
|
June |
Appendix 3B |
|
May |
Share Purchase Plan - Announcement |
|
May |
Share Purchase Plan - Rules |
|
May |
Share Purchase Plan - Cleansing Notice |
|
May |
Share Purchase Plan - Letter to Eligible Shareholders |
|
May |
Share Purchase Plan - Letter to Ineligible Shareholders |
|
May |
Share Purchase Plan - Letter to Optionholders |
|
May |
Announcement - Spring Tree Funding Facility |
|
May |
Notice 708A |
|
May |
Appendix 3B |
|
May |
Notice of Meeting |
|
May |
Investor Update |
|
April |
Quarterly Update to Investors - Q2 2010 |
|
April |
Appendix 4C - Quarterly |
|
April |
Appendix 3B - Amended |
|
April |
Correction to incorrect information in the market |
|
April |
Appendix 3B |
|
April |
Change in Convertible Note terms |
|
March |
Change in Substantial Shareholder |
|
March |
Appendix 3Y |
|
March |
Appendix 3B |
|
March |
Announcement - Milestone Achievement under Option Agreement with NN |
|
March |
Announcement - Milestone Achievement |
|
February |
Notice of Initial Substantial Shareholder |
|
February |
Notice of Initial Substantial Shareholder |
|
February |
Correction to Top 20 Shareholders |
|
February |
Appendix 3X - Initial Director's Interest Notice |
|
February |
ASX Announcement - Commencement of official quotation |
|
February |
Announcement - CBio lists on ASX |
|
February |
ASX Announcement - Admission to the offical list |
|
February |
Statement on number and period of restricted securities |
|
February |
Listing Application and Agreement |
|
February |
Announcement - CBio successfully closes IPO |
|
January |
Announcement |
|
|
|
|
2009 |
|
|
December |
Further Supplementary Prospectus |
|
December |
Release |
|
November |
Supplementary to IPO Prospectus |
|
November |
Annual General Meeting - Managing Director's Address |
|
November |
Annual General Meeting - Results of Meeting |
|
November |
CBio Limited IPO Prospectus |
|
October |
Notice of Meeting and Explanatory Memorandum |
|
October |
Media Release |
|
October |
CBio Constitution |
|
October |
Results of EGM |
|
October |
Chairman's Address to EGM |
|
September |
Notice of Meeting |
|
August |
|
|
July |
Information Release |
|
June |
Information Release |
|
April |
Information Release |
|
January |
Information Release |
|
|
|
|
2008 |
|
|
December |
Second Supplementary Prospectus |
|
November |
Annual General Meeting of Shareholders - Chairman's Address |
|
November |
Annual General Meeting of Shareholders - Managing Director's Address |
|
November |
Annual General Meeting of Shareholders - Results of Meeting |
|
November |
Supplementary Prospectus |
|
November |
Notice of Meeting - AGM |
|
October |
CBio Limited Rights Issue Prospectus |
|
June |
Announcement: Commencement of dosing in Phase IIa RA clinical trial |
|
June |
Shareholder Newsletter |
|
May |
Information Release - CBio commences Phase IIa RA clinical trial |
PDF |
May |
Disclosure Announcement - CBio signs agreement with Novo Nordisk |
PDF |
May |
Information Release - Cpn10: Evidence of Utility Beyond a Single Indication |
|
April |
Disclosure Announcement - Receipt of Transaction Proposal |
|
| |
|
|
2007 |
|
|
November |
AGM - Chairman's Address to Shareholders |
|
November |
AGM - Managing Director's Address to Shareholders |
|
November |
Notice - Cancellation of EGM |
|
October |
Announcement - Apointment to the Board of Directors , Dr Peter Corr |
|
October |
Notice of Meeting - AGM |
|
October |
Disclosure Announcement - Ceasing to be a substantial shareholder, VLA |
|
October |
Shareholder Announcement - Notice of EGM |
|
October |
Announcement - Appointments to the Board of Directors |
|
July |
Substantial Holder Notice |
|
July |
Substantial Holder Notice |
|
May |
Second Further Suplementary Prospectus |
|
April |
Further Supplementary Prospectus |
|
April |
Supplementary Prospectus |
|
March |
Prospectus |
|
|
|
|
|
|
|
2006 |
|
|
December |
Letter to Shareholders |
|
November |
Chairman's address at AGM |
|
November |
CEO's address at AGM |
|
November |
Letter to Shareholders |
|
August |
|
|
August |
BioCentury News Artlcle on CBio |
|
August |
Information Release - Rheumatoid Arthritis |
|
August |
Summary of Media Articles |
|
August |
Disclosure Announcement - Investment Update |
|
August |
Disclosure Announcement - Sale of Bresagen Shares |
|
June |
Information Release - Completion of Phase 2a clinical trial in Multiple Sclerosis |
|
June |
Information Release - Completion of Phase 2a clinical trial in Psoriasis |
|
May |
Information Release - Completion of Phase 2a clinical trial in Rheumatoid Arthritis |
|
April |
Letter to Shareholders |
|
|
|
|
|
|
|
2005 |
|
|
December |
Letter to Shareholders |
|
November |
Chairman's address at AGM |
|
June |
Information Release - Federal Government Grant |
|
June |
Letter to Shareholders |
|
May |
Information Release - Termination of Phase 11(a) Clinical Trial in Ulcerative Colitis |
|
April |
Federal Govt awards CBio $6m |
|
April |
News Article - Australian Financial Review |
|
March |
CBio signs agreement with Griffith University for Phase IIa trial in MS |
|
February |
The Journal of Biological Chemistry Article |
|
January |
Prospectus |
|
|
|
|
|
|
|
2004 |
|
|
October |
Letter to Shareholders |
|
| June |
Information Memorandum |
PDF |
| |
|
|
| 2003 |
|
|
| November |
Replacement Prospectus |
PDF |
| November |
Prospectus |
PDF |
| |
|
|
| 2001 |
|
|
| June |
Prospectus |
PDF |
| |
|
|
